Acetylisoeugenol标准品

订购须知：

1.优势：高效稳定的专业纯化技术，完善的库存及供应体系，高效的销售团队。

2.包装规格：常规包装，如有特殊需求，我们根据客户要求包装。

3.运输方式：默认顺丰快递，大宗货物走德邦物流。

4.质量保证：严格的质量控制，通过**的检测，是质量保证的基础。如有异议经我司确认可无条件退换货。

【友情提示】：本产品仅供科研研究使用，不得用于人体临床直接检测。避免给您带来不必要的损失，请仔细阅读购买说明！

产品名称：Acetylisoeugenol

CAS No.：93-29-8

中文名：乙酰基异丁香酚

别名：

分子式：C12H14O3

性状：Powder

纯度：99.0%

特色优势：

1. 长达16年对照品的专业**及标准制定

2. 高效稳定纯化技术-高速逆流色谱技术的运用

3. 特有的高速逆流色谱对照品**中心及生产中心，保证对照品的质量可控性及批量生产的稳定性

4. 严格的质量控制，通过**的检测（1HNMR 13CNMR MS HPLC）

5. 部分对照品已获得国家质量监督检验检疫总局颁发的标准物质证书

6. 完善的库存及供应体系，所有产品均能现货供应

7. 高效的团队，99%的咨询可即时回复

8. 已在瑞士、新加坡、泰国、韩国、比利时、西班牙等十三个国家设立代理商

9. 已成为国家标准实验室标准品制备分实验室。

标准物质的特性分为五大类：

1、化学成分类：标准物质，纯的化合物或是有代表性的基体样品，天然的或添加(被)分析物的(如，用作农药残留分析的添加了杀虫剂的动物脂肪)，以一种或多种化学或物理化学特性值表征。

2、生物和临床特性类：与目录A相似的标准物质，但以一种或多种生化或临床特性值表征，如酶活性。

3、物理特性类：以一种或多种物理特性值表征的标准物质，如熔点、粘性和密度。

4、工程特性类：以一种或多种工程特性值表征的标准物质，如硬度、拉伸强度和表面特性。

5、其他特性。这些类别又被细分为三级子类，例如，在化学成分类中，以微量锰、硅、铜、镍和铬含量表征的铝合金，列于化学成分一金属一有色金属一铝合金的子类中；在化学成分类别中，标准物质还可进一步被分为单一成分的标准物质和基体标准物质两大类；单一成分的标准物质是纯物质(元素或化合物)，或纯度、浓度、熔点、熔化焓值、粘度、紫外可见光吸光率、闪点等参考值已确定的纯物质的溶液；这类标准物质的重要用途之一是分析仪器 的检定或校准。
血小板反应蛋白2/凝血酶敏感蛋白2抗体储 存 液  Preservative: 15mM Sodium Azide, Constituents: 1% BSA, 0.01M PBS, pH 7.4 α1-微球蛋白检测试剂盒

四分子交联体17抗体（四旋蛋白）产品应用   WB=1:100-500  ELISA=1:500-1000  IP=1:20-100  IHC-P=1:100-500  IHC-F=1:100-500  IF=1:100-500 α7型神经烟碱胆碱能受体检测试剂盒

髓系触发受体1抗体（石蜡切片需做抗原修复） αL岩藻糖苷酶检测试剂盒

紧密连接蛋白2抗体 not yet tested in other applications.α-氨基羟甲基恶唑酸检测试剂盒

磷酸化埃兹蛋白抗体 optimal dilutions/concentrations should be determined by the end user.  α淀粉酶检测试剂盒

单克隆抗体保存条件  Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C. α-防御素检测试剂盒

微管相关蛋白α6抗体Important Note  This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications. α干扰素检测试剂盒

T转录调节因子TFEB抗体Tissue specificity;Expressed in brain, placenta, kidney, neuron and skeletal muscle.α谷胱甘肽S转移酶检测试剂盒

转铁蛋白单克隆抗体Involvement in diseaseDefects in PNPLA6 are the cause of spastic paraplegia autosomal recessive type 39 (SPG39) ; also known as NTE-related motor neuron disorder (NTEMND). Spastic paraplegia is a neurodegenerative disorder characterized by a slow, gradual, progressive weakness and spasticity of the lower limbs. Rate of progression and the severity of symptoms are quite variable. Initial symptoms may include difficulty with balance, weakness and stiffness in the legs, muscle spasms, and dragging the toes when walking. In some forms of the disorder, bladder symptoms (such as incontinence) may appear, or the weakness and stiffness may spread to other parts of the body. SPG39 is associated with a motor axonopathy affecting upper and lower limbs and resulting in progressive wasting of distal upper and lower extremity muscles.α黑色素检测试剂盒

促甲状腺素抗体Function : Phospholipase B that deacylates intracellular phosphatidylcholine (PtdCho), generating glycerophosphocholine (GroPtdCho). This deacylation occurs at both sn-2 and sn-1 organophosphorus (OP) compounds leads to distal axonopathy.α平滑肌肌动蛋白检测试剂盒

促甲状腺素单克隆抗体Subcellular Location : Endoplasmic reticulum membrane; Single-pass ype I membrane protein; Cytoplasmic side. Note=Anchored to the cytoplasmic face of the endoplasmic reticulum by its amino-terminal transmembrane segment.α葡萄糖苷酶检测试剂盒

磷酸化转化生长因子β活化激酶1Tissue Specificity : Expressed in brain, placenta, kidney, neuron and skeletal muscle.α羟基丁酸脱氢酶检测试剂盒

特异性Y蛋白样5抗体Post-translational modifications : Glycosylated.α酮戊二酸脱氢酶检测试剂盒

转化生长因子β1抗体DISEASE : Defects in PNPLA6 are the cause of spastic paraplegia autosomal recessive type 39 (SPG39) [MIM:612020]; also known as NTE-related motor neuron disorder (NTEMND). Spastic paraplegia is a neurodegenerative disorder characterized by a slow, gradual, progressive weakness and spasticity of the lower limbs. Rate of progression and the severity of symptoms are quite variable. Initial symptoms may include difficulty with balance, weakness and stiffness in the legs, muscle spasms, and dragging the toes when walking. In some forms of the disorder, bladder symptoms (such as incontinence) may appear, or the weakness and stiffness may spread to other parts of the body. SPG39 is associated with a motor axonopathy affecting upper and lower limbs and resulting in progressive wasting of distal upper and lower extremity muscles.β2微球蛋白检测试剂盒
Acetylisoeugenol标准品PH：7.1±0.2

用法：称取本品50克，溶解于1000ml蒸馏水中，分装三角瓶，每瓶200ml,121℃高压灭20分钟，冷至45-50℃加入无亚碲酸钾0.5mg，噻孢霉素0.01mg（或加入一支山梨醇麦康凯琼脂添加剂)，混匀,倾入无平皿备用

性状(以下信息仅供参考)：干燥粉末。易潮解。

用途：本品仅供科研，不得用于其它用途。(以下用途仅供参考)用于大肠杆O157：H7的选择性分离培养

保存：RT

产品名称：MUG培养基

英文名称：MUG-Medium（with Kovacs）

其他名称：MUG培养基

级别：BR

产品留言

标题

联系人

联系电话

内容

验证码

点击换一张

注：1.可以使用快捷键Alt+S或Ctrl+Enter发送信息!
2.如有必要,请您留下您的详细联系方式!